Newsroom

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic and infectious diseases, today announced corporate, financial, and pipeline updates in advance of its participation at the 2026 J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco. Throughout the conference, Turn Therapeutics will participate in investor and partner meetings to...

PHILADELPHIA & SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, and CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, today announced a clinical collaboration to conduct a Phase 1 trial in China, planned to begin in 2026. The trial will evaluate DISP-11, an investigational therapy leveraging Disp...

SAN DIEGO--(BUSINESS WIRE)--Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity verification and fraud prevention, has been recognized for its strong performance in a recent independent evaluation by Datos Insights, a respected financial services research and advisory firm. In the Datos Insights Matrix for Document Identity Verification, Mitek was positioned as a Market Leader, demonstrating strong performance across both product capabilities and execution, the core dimensio...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenue for Q4 and full year 2025 of approximately $243 million and $868 million, respectively. The company continues to build on six consecutive years of revenue growth. On track to extend the pitolisant franchise, Harmony fortifies its profile as a profitable, self-funding biotech company with a robust, late-stage pipeline and strong long-term gro...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 09.01.2026 FVD. IE00BKVKW020 250,002.00 USD 7,101,771.18 28.407  ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ETX101 for the treatment of SCN1A+ Dravet syndrome. This designation is in addition to Regenerative Medicine Advanced Therapy (RMAT), Fast Track, Orphan Drug, and Rare Pediatric Disease D...

BELOIT, Wis.--(BUSINESS WIRE)--Fairbanks Morse Defense (FMD) has announced the expansion of its robotic welding program aimed at boosting ship repair and maintenance efficiency for the U.S. Navy and allied fleets. The company’s robotic welding technology combines automation, precision and data-driven performance to reduce operational downtime, improve safety and extend the service life of naval assets. FMD’s robotics integrate advanced machine learning technology that enables automated weld con...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “We enter 2026 with strong momentum and...

SAN FRANCISCO--(BUSINESS WIRE)--Junevity Announces First Peer-reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging...

Dallas y Ciudad de México--(BUSINESS WIRE)--VelaFi, una plataforma de infraestructura financiera impulsada por stablecoins y parte de Galactic Holdings, anunció hoy el cierre de su ronda de financiación Serie B por 20 millones de dólares, liderada por XVC e Ikuyo, con la participación de Alibaba Investment, Planetree, BAI Capital (accionista actual) y otros inversionistas globales. Con esta ronda, la financiación total de VelaFi supera los 40 millones de dólares. Fundada en 2020, VelaFi tiene r...